
Chemcrux Enterprises (CHEMCRUX) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
165.0M
Gross Profit
85.3M
51.66%
Operating Income
4.5M
2.72%
Net Income
927.0K
0.56%
EPS (Diluted)
₹0.06
Balance Sheet Metrics
Total Assets
1.3B
Total Liabilities
524.2M
Shareholders Equity
746.2M
Debt to Equity
0.70
Cash Flow Metrics
Revenue & Profitability Trend
Chemcrux Enterprises Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 700.1M | 573.5M | 807.7M | 820.1M | 533.3M |
Cost of Goods Sold | 274.2M | 501.5M | 594.4M | 603.5M | 207.8M |
Gross Profit | 425.9M | 72.0M | 213.3M | 216.7M | 325.5M |
Gross Margin % | 60.8% | 12.6% | 26.4% | 26.4% | 61.0% |
Operating Expenses | |||||
Research & Development | - | - | 0 | 1.2M | - |
Selling, General & Administrative | - | 35.4M | 31.1M | 44.1M | 19.6M |
Other Operating Expenses | 247.9M | 23.4M | 31.7M | 33.9M | 138.8M |
Total Operating Expenses | 247.9M | 58.8M | 62.8M | 79.2M | 158.4M |
Operating Income | 60.2M | 112.2M | 194.1M | 190.9M | 113.5M |
Operating Margin % | 8.6% | 19.6% | 24.0% | 23.3% | 21.3% |
Non-Operating Items | |||||
Interest Income | - | 3.9M | 2.6M | 915.0K | 751.0K |
Interest Expense | 17.5M | 7.1M | 6.5M | 1.4M | 1.5M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 57.6M | 114.3M | 196.5M | 199.5M | 120.5M |
Income Tax | 18.5M | 29.9M | 52.9M | 51.0M | 31.1M |
Effective Tax Rate % | 32.1% | 26.1% | 26.9% | 25.6% | 25.8% |
Net Income | 39.1M | 84.4M | 143.6M | 148.6M | 89.3M |
Net Margin % | 5.6% | 14.7% | 17.8% | 18.1% | 16.8% |
Key Metrics | |||||
EBITDA | 107.1M | 143.7M | 219.4M | 214.2M | 133.5M |
EPS (Basic) | ₹2.64 | ₹5.70 | ₹9.70 | ₹10.03 | ₹6.03 |
EPS (Diluted) | ₹2.64 | ₹5.70 | ₹9.70 | ₹10.03 | ₹6.03 |
Basic Shares Outstanding | 14824242 | 14809000 | 14809000 | 14809000 | 14815297 |
Diluted Shares Outstanding | 14824242 | 14809000 | 14809000 | 14809000 | 14815297 |
Income Statement Trend
Chemcrux Enterprises Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 10.2M | 709.0K | 11.8M | 117.6M | 26.1M |
Short-term Investments | 199.8M | 247.7M | 225.3M | 70.4M | 87.5M |
Accounts Receivable | 117.8M | 153.0M | 134.4M | 188.8M | 33.1M |
Inventory | 100.2M | 84.1M | 140.9M | 115.7M | 73.7M |
Other Current Assets | 32.9M | 13.7M | 74.8M | 894.0K | 685.1K |
Total Current Assets | 463.3M | 502.9M | 552.0M | 548.3M | 275.5M |
Non-Current Assets | |||||
Property, Plant & Equipment | 762.5M | 21.3M | 21.3M | 20.9M | 17.9M |
Goodwill | 1.3M | 154.0K | 665.0K | 1.1M | 220.0K |
Intangible Assets | 1.3M | 154.0K | 165.0K | 97.0K | 220.0K |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | 1.2M | 1.2M | 10.0K |
Total Non-Current Assets | 807.2M | 595.7M | 380.2M | 289.4M | 222.0M |
Total Assets | 1.3B | 1.1B | 932.2M | 837.7M | 497.5M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 44.9M | 70.3M | 80.3M | 116.0M | 20.0M |
Short-term Debt | 136.5M | 41.5M | 32.6M | 81.0M | 5.1M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 11.8M | 16.2M | 13.0M | 15.3M | 8.1M |
Total Current Liabilities | 200.4M | 129.5M | 138.4M | 261.5M | 63.2M |
Non-Current Liabilities | |||||
Long-term Debt | 286.5M | 223.0M | 111.6M | 16.5M | 15.7M |
Deferred Tax Liabilities | 36.7M | 21.8M | 18.1M | 12.8M | 11.0M |
Other Non-Current Liabilities | 1.0K | - | 4.0K | 1.0K | -1.0K |
Total Non-Current Liabilities | 323.8M | 246.5M | 129.7M | 29.3M | 26.7M |
Total Liabilities | 524.2M | 376.1M | 268.1M | 290.9M | 89.9M |
Equity | |||||
Common Stock | 148.1M | 148.1M | 148.1M | 148.1M | 49.4M |
Retained Earnings | - | 567.0M | 512.2M | 398.2M | 347.5M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 746.2M | 722.6M | 664.1M | 546.8M | 407.6M |
Key Metrics | |||||
Total Debt | 423.0M | 264.5M | 144.3M | 97.5M | 20.8M |
Working Capital | 262.9M | 373.4M | 413.6M | 286.7M | 212.2M |
Balance Sheet Composition
Chemcrux Enterprises Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 57.7M | 114.3M | 196.5M | 199.5M | 120.5M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 18.8M | 53.4M | -4.5M | -170.1M | 7.8M |
Operating Cash Flow | 86.4M | 176.1M | 200.2M | 31.1M | 129.8M |
Investing Activities | |||||
Capital Expenditures | -82.3M | -231.9M | -111.1M | -45.7M | -61.6M |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | - | - | -42.3M | -116.3M |
Investment Sales | - | - | - | 62.3M | 96.3M |
Investing Cash Flow | -82.3M | -231.8M | -111.1M | -25.7M | -81.6M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -14.8M | -29.6M | -29.6M | -9.9M | -4.9M |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | 21.0M | -29.3M | -84.0M | 40.2M | -402.1K |
Free Cash Flow | -8.0M | -77.5M | 36.5M | 45.6M | 25.9M |
Net Change in Cash | 25.1M | -85.0M | 5.1M | 45.6M | 47.8M |
Cash Flow Trend
Chemcrux Enterprises Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
62.73
Price to Book
2.32
Price to Sales
2.50
PEG Ratio
-0.68
Profitability Ratios
Profit Margin
3.99%
Operating Margin
2.72%
Return on Equity
5.24%
Return on Assets
3.08%
Financial Health
Current Ratio
2.31
Debt to Equity
56.68
Beta
-0.34
Per Share Data
EPS (TTM)
₹1.87
Book Value per Share
₹50.64
Revenue per Share
₹46.27
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
chemcrux | 1.7B | 62.73 | 2.32 | 5.24% | 3.99% | 56.68 |
Asian Paints | 2.4T | 67.58 | 12.50 | 18.28% | 10.63% | 11.42 |
Pidilite Industries | 1.6T | 71.94 | 16.09 | 20.85% | 16.16% | 4.56 |
Tanfac Industries | 46.6B | 48.54 | 14.95 | 32.50% | 15.83% | 13.28 |
Kingfa Science | 46.2B | 30.12 | 6.35 | 20.98% | 8.58% | 5.90 |
Grauer & Weil | 42.1B | 26.73 | 4.48 | 16.73% | 13.35% | 1.26 |
Financial data is updated regularly. All figures are in the company's reporting currency.